These compounds may interact with:
Serine/threonine-protein kinase mTOR
Potentially involved in: intellectual disability; epilepsy; globe disease; endometrial cancer; breast cancer; kidney cancer; carcinoma; large intestine cancer; cancer; lymphangioleiomyomatosis; subependymal giant cell astrocytoma; stomatitis; diabetes mellitus; kidney angiomyolipoma; obesity; kidney disease; vascular disease; mucositis; tuberous sclerosis; hyperglycemia
Disease data sourced from Pharos.